Dublin, Nov. 18, 2016 -- Research and Markets has announced the addition of the "Aesthetic/Cosmetic Lasers Market by Type (Standalone (CO2, Er:YAG, Diode, Nd:YAG, Alexandrite, Pulsed-Dye), Multiplatform), Application (Acne, Scars, Tattoo Removal, Varicose Veins), End User (Hospitals, Medical Spa, Private clinics) - Forecasts to 2021" report to their offering.
The global aesthetic/cosmetic lasers market is projected to reach USD 1,132.7 million by 2021 from USD 697.6 million in 2016, growing at a CAGR of 10.2% during the forecast period.
Growth of this market can be attributed to factors such as growing adoption of noninvasive procedures, changing lifestyles, rising incidence of skin damage, reduction in procedural costs, and rising medical tourism. However, lack of reimbursement of cosmetic laser based procedures is restraining the growth of this market.
Multiplatform lasers provide clinicians the flexibility and versatility of several standalone systems in a single package, and provide combination therapy to synergistically treat a single indication or provide treatment addressing multiple elements of any indication. Thus, this segment is expected to grow at the highest CAGR during the forecast period.
The skin rejuvenation segment is expected to grow at the highest CAGR during forecast period, due to factors such as rise in population with skin disorders and concerns, growing adoption of aesthetic procedures, and technological advancement in lasers. Furthermore, the hair removal segment is expected to have the largest market size in 2016, due to the factors such as high adoption of aesthetic procedures, developments in laser technology, increased focus on body appearance, and high disposable income.
The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (expansions; new product launches; marketing and promotion; agreements, collaborations, contracts, partnerships, and joint ventures; funding; acquisitions; patent grants, website launches, and product enhancement) to increase their market shares and establish a strong foothold in the global aesthetic/cosmetic lasers market.
Major players in the aesthetic/cosmetic lasers market include
- Aerolase
- Alma Lasers
- Cutera, Inc.
- Cynosure, Inc.
- El.En SpA
- Lumenis Ltd.
- Sciton, Inc.
- Sharplight Technologies Ltd.
- Solta Medical, Inc.
- Syneron Medical Ltd.
For more information about this report visit http://www.researchandmarkets.com/research/nntrvb/aestheticcosmetic
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cosmetics, Surgical Devices , Lasers


Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 



